Marc Scheineson is quoted on key considerations for the Food & Drug Administration and Congress in rulemaking on the lawful use of CBD in supplements and other products.
In the News
May 17, 2022
HBWInsight, Rose Sheet | Hemp Roundtable Says Safety Study Data Should Convince Congress on Lawful CBD Use
Media Contact